IDEAYA Biosciences — Fact Sheet (November 2022)

2 slides from IDEAYA Biosciences's fact sheet, Nov 8, 2022

Slide 1: IDEAYA Highlights
IDEAYA Highlights Breakthrough Science on transformative programs in Synthetic Lethality – an emerging November 2022 area of precision medicine Broad Pipeline of potential first-in-class precision medicine oncology programs with defined patient biomarkers Proven Management Team with deep business an
Slide 2: IDEAYA Biosciences – Fact Sheet
IDEAYA Biosciences – Fact Sheet Founded 2015 on the thesis that Synthetic Lethality would emerge as a central focus of precision medicine oncology, with significant Pharma interest and the potential to develop first-in-class therapeutics for biomarker-defined cancer patient populations. Broad Pipeli